• Targeting Sickle Cell Disease

  • Oct 24 2022
  • Length: 16 mins
  • Podcast

Targeting Sickle Cell Disease

Listen for free

View show details

  • Summary

  • Terri Booker’s body burns with pain. She’s one of the 100,000 Americans living with sickle cell disease – a blood disorder that can cause severe pain, organ failure, and even premature death. The genetic condition came about to protect against malaria. Dr. William Hobbs leads clinical development for sickle cell disease at Vertex, and they are investigating multiple approaches to address the unmet needs that patients face.

    Produced by Bloomberg Media Studios and Vertex Pharmaceuticals.

    Featured guests:

    Terri Booker is an attorney and sickle cell advocate based in Philadelphia, Pennsylvania.

    Dr. Isaac Odame  is the Haematology Section Head in the Division of Haematology/Oncology and the Medical Director of the Global Sickle Cell Disease Network at the Centre for Global Child Health at The Hospital for Sick Children.

    Dr. David Altshuler is the Executive Vice President, Global Research and Chief Scientific Officer at Vertex Pharmaceuticals.

    Dr. William Hobbs is the VP- Clinical Development, Hematology at Vertex Pharmaceuticals.

    Read more about Vertex's approach to targeting sickle cell disease

    Show more Show less
Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Targeting Sickle Cell Disease

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available